BamSEC and AlphaSense Join Forces
Learn More

Akebia Therapeutics Inc.

NASDAQ: AKBA    
Share price (1/8/25): $1.79    
Market cap (1/8/25): $391 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.5
from 10-Q 3 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. Amendment #1 to Supply Agreement
12/34/56
EX-10.4
from 10-Q ~1 page Amendment #1 to License Agreement
12/34/56
EX-10.4
from 10-Q 16 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. Termination and Settlement Agreement
12/34/56
EX-10.3
from 10-Q 4 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. Amendment #1 to the Second Amended and Restated License Agreement
12/34/56
EX-10.2
from 10-Q 2 pages Amendment #2 to Supply Agreement
12/34/56
EX-10.1
from 10-Q 4 pages Seventh Amendment to Lease
12/34/56
EX-10.11
from 10-Q 8 pages March 15, 2024 by Email 1. Separation Date; Final Payments; Benefits Cessation
12/34/56
EX-10.103
from 10-K 7 pages Warrant Agreement
12/34/56
EX-10.93
from 10-K 9 pages Agreement
12/34/56
EX-10.67
from 10-K 1 page February 7, 2024 by Email /S/ John P. Butler /S/Michel Dahan President and Chief Executive Officer Michel Dahan Dated: February 8, 2024
12/34/56
EX-10.66
from 10-K 1 page February 8, 2024 by Email /S/ John P. Butler /S/ Nicole R. Hadas President and Chief Executive Officer Nicole R. Hadas Dated: February 8, 2024
12/34/56
EX-10.47
from 10-K 6 pages Akebia Therapeutics, Inc. Officer Inducement Award Stock Option Agreement
12/34/56
EX-10.46
from 10-K 7 pages Akebia Therapeutics, Inc. Restricted Stock Unit Agreement for Officers 2023 Stock Incentive Plan
12/34/56
EX-10.45
from 10-K 7 pages Akebia Therapeutics, Inc. Stock Option Agreement for Officers 2023 Stock Incentive Plan
12/34/56
EX-10.44
from 10-K 4 pages Material contract
12/34/56
EX-10.43
from 10-K 8 pages Executive Severance Agreement
12/34/56
EX-10.21
from 10-K 4 pages Akebia Therapeutics, Inc. Third Amended and Restated Non-Employee Director Compensation Program Effective January 1, 2024
12/34/56
EX-10.3
from 10-Q 1 page Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions
12/34/56
EX-10.14
from 10-Q 6 pages Akebia Therapeutics, Inc. Officer Inducement Award Stock Option Agreement
12/34/56
EX-10.13
from 10-Q 7 pages Akebia Therapeutics, Inc. Restricted Stock Unit Agreement for Officers 2023 Stock Incentive Plan
12/34/56